Gallium maltolate taken by mouth for glioblastoma that has come back
Official title: Oral Gallium Maltolate for Recurrent Glioblastoma
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This trial checks whether a drug taken by mouth reaches brain tumor tissue.
Read our full plain-language summary
What the trial team says
This is a Phase 0 investigational study to assess the central nervous system penetration and tumoral concentration of gallium in patients with recurrent glioblastoma administered with preoperative gallium maltolate.
Key facts
- Registry number
- NCT07515924
- Stage of testing
- Early phase 1
- Conditions studied
- Glioblastoma
Where it is running
This trial lists 1 site.
-
Wisconsin
- Froedtert & the Medical College of Wisconsin (Milwaukee)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.